Related Topics

    Nienhuis: News Releases & Feature Stories

    A Giant Step for Gene Therapy

    Exciting gene therapy study helps patients with hemophilia B.

    Hematologist Arthur Nienhuis named 2009 ASH Mentor Award recipient

    Arthur Nienhuis, M.D., of St. Jude Children’s Research Hospital, is the recipient of the 2009 Mentor Award from the American Society of Hematology (ASH).

    New leadership at St. Jude

    Former St. Jude Director Arthur W. Nienhuis, M.D., and George Simon, chair of the St. Jude Board of Governors, recently announced that William E. Evans, Pharm.D., assumed the position of St. Jude Director and CEO. Nov. 1, 2004.

    St. Jude researchers reverse blood disease using genetically modified stem cells

    Researchers at St. Jude Children's Research Hospital have overcome two major technical obstacles that currently limit the success of gene therapy for human red blood cell diseases such as beta-thalassemia and sickle cell disease.

    St. Jude faculty elected to Institute of Medicine

    Arthur Nienhuis, M.D., and William Evans, Pharm.D., of St. Jude Children's Research Hospital have been elected to the Institute of Medicine, a prestigious branch of the National Academy of Sciences.